Pfizer Inc (PFE)

PFE (NYSE:Drugs) EQUITY
$32.22
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | PFE Avg Daily Volume: 23,737,600
Last Update: 08/31/15 - 4:00 PM EDT
Volume: 0
YTD Performance: 3.44%
Open: $0.00
Previous Close: $32.22
52 Week Range: $27.51 - $36.46
Oustanding Shares: 6,167,347,758
Market Cap: 201,425,577,776
6-Month Chart
TheStreet Ratings Grade for PFE
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 7
Moderate Buy 0 0 0 0
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.92 1.92 1.92 2.00
Latest Dividend: 0.28
Latest Dividend Yield: 3.43%
Dividend Ex-Date: 08/05/15
Price Earnings Ratio: 23.16
Price Earnings Comparisons:
PFE Sector Avg. S&P 500
23.16 23.20 25.39
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-7.28% 9.63% 35.04%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.80 -0.26 -0.10
Net Income -58.50 0.04 0.01
EPS -55.50 0.13 0.04
Earnings for PFE:
EBITDA 19.04B
Revenue 49.61B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $0.50 $0.49 $2.06 $2.32
Number of Analysts 9 7 12 12
High Estimate $0.54 $0.50 $2.08 $2.65
Low Estimate $0.49 $0.47 $2.05 $2.12
Prior Year $0.57 $0.54 $2.26 $2.06
Growth Rate (Year over Year) -11.70% -9.79% -8.85% 12.62%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Aug 27, 2015 | 6:12 AM EDT

At first glance there is little connection, but you need to look deeper.

By

Sebastian Silva

 | Aug 25, 2015 | 12:01 PM EDT

USA Today's '9 Stocks' story doesn't consider data essential to its narrative.

By

Jim Collins

 | Aug 24, 2015 | 1:00 PM EDT

Limit your purchases to high-yielding industry standouts.

By

Bruce Kamich

 | Aug 20, 2015 | 1:05 PM EDT

And 16 names are weak to ugly.

By

Jim Cramer

 | Aug 1, 2015 | 9:00 AM EDT

Jim Cramer, portfolio manager of Action Alerts PLUS, and research director Jack Mohr sat down to talk about their 'favorite company in the portfolio:' Allergan.

By

David Katz

 | Jul 30, 2015 | 11:00 AM EDT

Drugmaker has one of the best showings of earnings season.

By

David Katz

 | Jul 30, 2015 | 8:30 AM EDT

Drugmaker has one of the best showings of earnings season.

By

Timothy Collins

 | Jul 29, 2015 | 10:55 AM EDT

PFE now has a very large bull flag with the potential to push the shares higher.

By

Jim Cramer

 | Jul 16, 2015 | 2:51 PM EDT

They should learn to trust techs, financials.

By

Dick Arms

 | Jul 16, 2015 | 7:00 AM EDT

If you went long last week, take profits, but don't go short just yet.

Amid the doom and gloom, a bit of good news from the European Central Bank: the bank has d...
Chinese PMI data is once again sending global stocks deep into the red as worries the dual...

S and Ps -34
Nazzies -81

Remember $BTC Bitcoin? "Barclays has a team working on about 20 Bitcoin-related experimen...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.